The new “pressurized olfactory device,” currently being tested on animals, is a noninvasive approach that could relieve pain with fewer side effects and faster onset of action.
Researchers at the University of Washington have used the device to deliver morphine with pinpoint precision directly to the olfactory region of the nasal cavity.
Related Articles on Pain Medications:
8 Pain Medication Mistakes Patients Make
Global Pain Medication Sales Rise 8.9% Since 2005
Study: Addiction to Meds Common for Chronic Pain Patients
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
